Division of Intramural Clinical and Biological Research

Full Text Version   May 2024

Organizational Chart Description

Office of the Scientific Director

David M. Lovinger, PhD, Scientific Director
Bin Gao, PhD, Deputy Scientific Director

Office of Laboratory Animal Sciences

Vacant, Chief

Board of Scientific Counselors

Office of Clinical Director

David Goldman MD, Clinical Director
Nancy Diazgranados, MD, MS, Deputy Clinical Director

• Clinical Core Laboratory
  David Goldman MD, Chief
   
• Clinical Neuroimaging Research Core Laboratory
  Reza Momenan, PhD, Director
   
• Section on Clinical Genomics and Experimental Therapeutics (CGET)
  Falk Lohoff, MD, Acting Chief
   
• Laboratory on Human Psychpharmacology (HP)
  Vijay Ramchandani, PhD, Chief
   
• Laboratory on Clinical Psychoneuroendocrinology and Neuropsychopharmacology (CPN)
  Joint Laboratory of National Institute on Alcohol Abuse and Alcoholism (NIAAA) and National Institute on Drug Abuse (NIDA)
  Lorenzo Leggio, MD/PhD/MSc, Chief
   
• Section of Sensory Science and Metabolism (SSSM)
  Joint Laboratory of National Institute on Alcohol Abuse and Alcoholism (NIAAA) and National Institute of Nursing Research (NINR)
  Paule V. Joseph, Ph.D., MS, FNP-BC, CTN-B, Acting Chief

Laboratory on Cardiovascular Physiology & Tissue Injury (LCPTI)

Pal Pacher, MD, PhD, Chief

Section of Molecular Pharmacology & Toxicology (SMPT)

Byoung J. Song, PhD, Chief

Laboratory of Neurogenetics (LNG)

David Goldman, MD, Chief

Laboratory for Integrative Neuroscience (LIN)

David M. Lovinger, PhD, Chief

• Unit on Motivation and Arousal (UMA)
  Andrew Kesner, Ph.D., Unit Chief

Laboratory of Physiologic Studies (LPS)

George Kunos, MD/PhD, Chief

Laboratory of Biophotonics and Quantum Biology (LBQB)

Steven S. Vogel, PhD,  Chief 

Laboratory on the Neurobiology of Compulsive Behavior (LNCB)

Joint Laboratory of National Institute on Alcohol Abuse and Alcoholism (NIAAA) and National Institute of Mental Health (NIMH)
Veronica Alvarez, PhD, Chief

Laboratory of Neuroimaging (LNI)

Nora D. Volkow, MD, Chief

Laboratory of Behavioral and Genomic Neuroscience (LBGN)

Andrew Holmes, PhD, Chief

Laboratory of Molecular Signaling (LMS)

Hee-Yong Kim, PhD, Chief

Laboratory of Liver Diseases (LLD)

Bin Gao, MD/PhD, Chief